13D Filing: Longwood Fund II, L.P. and Kalvista Pharmaceuticals Inc. (KALV)

Page 9 of 9

Page 9 of 9 – SEC Filing


CUSIP No. 483497103 Page 9 of 10

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.

Date: October 20, 2017

LONGWOOD FUND II, L.P.
By: Longwood Fund II GP, LLC, its general partner
By: /s/ Christoph Westphal, M.D., Ph.D.

Manager

LONGWOOD FUND II GP, LLC
By:

/s/ Christoph Westphal, M.D., Ph.D.

Manager
CHRISTOPH WESTPHAL, M.D., PH.D.
By:

/s/ Christoph Westphal, M.D., Ph.D.

Christoph Westphal, M.D., Ph.D.
RICHARD ALDRICH
By:

/s/ Richard Aldrich

Richard Aldrich

Follow Kalvista Pharmaceuticals Inc. (NASDAQ:KALV)

Page 9 of 9